🧬Rare & Orphan Diseases
Market Cap$299.7B
1D+1.32%
Companies239
Public Cos73
SECTOR MARKET CAP
$299.7B+255.7%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United Kingdom | $22.7B | ROIV |
| 2 |  | United States | $22.7B | UTHR |
| 3 |  | United States | $21.6B | INSM |
| 4 |  | Sweden | $16.1B | SOBI.ST |
| 5 |  | Denmark | $15.3B | ASND |
| 6 |  | France | $14.7B | IPN.PA |
| 7 |  | Ireland | $14.1B | JAZZ |
| 8 |  | United States | $13.2B | BBIO |
| 9 |  | Taiwan | $12.9B | 6446.TW |
| 10 |  | United States | $12.4B | IONS |
| 11 |  | Italy | $11.9B | REC.MI |
| 12 |  | United States | $11.7B | ARWR |
| 13 |  | United States | $10.8B | BMRN |
| 14 |  | United States | $10.4B | KRYS |
| 15 |  | United States | $8.3B | PRAX |
| 16 |  | Japan | $8.2B | 4151.T |
| 17 |  | United States | $6.8B | RYTM |
| 18 |  | United States | $6.7B | PTCT |
| 19 |  | United States | $6.7B | MIRM |
| 20 |  | United States | $6.6B | LQDA |